Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Spinal Cord InjuryPain
Interventions
DRUG

botulinum toxin A

Injection of BTXA into cervical and upper back muscles based on treatment plan prescribed for each participant individually based on muscle soreness and tightness. Injections occured on one single clinic visit.Both the saline and BTXA were dosed in 25 cc syringes and looked the same for the physician performing the injections to ensure both participant and study physician remained blinded.

OTHER

placebo

Injection of normal saline into cervical and upper back muscles was also based on treatment plan prescribed for each participant individually based on muscle soreness and tightness. Injections occured on one single clinic visit. Both the saline and BTXA were dosed in 25 cc syringes and looked the same for the physician performing the injections to ensure both participant and study physician remained blinded.

Trial Locations (1)

80113

Craig Hospital, Englewood

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Craig H. Neilsen Foundation

OTHER

collaborator

Allergan

INDUSTRY

lead

Craig Hospital

OTHER

NCT00320281 - Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury. | Biotech Hunter | Biotech Hunter